Arrhythmia drug tied to cancer risk in men, study finds

04/8/2013 | MedPage Today (free registration)

An analysis of data from a health database in Taiwan found that men who took the antiarrhythmia drug amiodarone had a nearly 20% increased risk of developing cancer compared with the general population. The risk was 46% greater among men with extensive exposure to the drug. Women, however, did not seem to have a higher risk, researchers reported in the journal Cancer.

View Full Article in:

MedPage Today (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT